Jianyang Dong

Jianyang Dong

Auto-generated profile, based on publicly available information

Jianyang Dong

Rehabilitation Medicine Department, Neuroscience Cluster, The Fourth People's Hospital of Shenzhen, Shenzhen, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2025 in Brain and Behavior
Verified
Journal Article
Open access
JDJianyang Dong
Jianyang Dong
MDMengying Dai
Mengying Dai
ZGZinan Guo
Zinan Guo
TXTing Xu
Ting Xu
FLFangming Li
Fangming Li
MDMengying Dai
Mengying Dai
Purpose: The purpose of this review is to evaluate the current state and potential future directions of deep brain stimulation (DBS) therapy for treatment‐resistant depression (TRD), a condition that significantly impacts patients' quality of life and for which conventional treatments are often ineffective.Method: This review synthesizes evidence from clinical trials and preclinical studies published in five years, identified through PubMed searches using keywords (“Deep Brain Stimulation” OR DBS) AND (“Treatment‐Resistant Depression” OR TRD). Included studies encompassed clinical research (randomized/non‐randomized trials, cohort studies) and mechanistic preclinical studies, excluding non‐English publications and nonhuman experiments. Screening prioritized neuroanatomical targets (e.g., SCG, NAcc) and stimulation parameter optimization data. Examining the therapeutic mechanisms of DBS, the neuroanatomical targets utilized, and the clinical outcomes observed. It also discusses the challenges faced in DBS application and proposes potential technological advancements, such as closed‐loop therapy and fiber tracking technology.Finding: Preliminary evidence exists regarding the efficacy and safety of DBS in the treatment of TRD in the subcortical cingulate gyrus (SCG), nucleus accumbens (NAcc), ventral capsule/ventral striatum (VC/VS), anterior limb of the internal capsule (ALIC), and so forth. Nevertheless, the optimal stimulation target remains undetermined. The review highlights the complexity of TRD and the need for personalized treatment strategies, noting that genetic, epigenetic, and neurophysiological changes are implicated in DBS's therapeutic effects.Conclusion: In conclusion, while DBS for TRD remains an experimental therapy, it offers a unique and potentially effective treatment option for patients unresponsive to traditional treatments. The review emphasizes the need for further research to refine DBS targets and parameters, improve patient selection, and develop personalized treatment plans to enhance efficacy and safety in TRD management.

3 July 2026 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
ZGZinan Guo
Zinan Guo
MDMengying Dai
Mengying Dai
SSShuo Song
Shuo Song
CNChengqing Ning
Chengqing Ning
ZLZheng Li
Zheng Li
JDJianyang Dong
Jianyang Dong
Traditional neuroanatomy long asserted the absence of lymphatic circulation in the central nervous system, contradicting its high metabolic activity and efficient waste removal. This paradox was resolved in the 21st century by Iliff et al., who discovered the glymphatic system (GS)—a glia-dependent network enabling cerebrospinal fluid to flow through periarterial spaces, clear interstitial waste via paravenous pathways, and drain into peripheral circulation through meningeal/cranial lymphatic routes. Beyond waste clearance, the GS mediates nutrient distribution and neuroactive signaling, fundamentally reshaping brain homeostasis concepts. Critically, emerging evidence reveals bidirectional links between glymphatic dysfunction and neurological diseases: impaired fluid dynamics both triggers and aggravates neurodegeneration and cerebrovascular pathologies through self-amplifying neuroinflammation and pathological protein accumulation. Existing reviews, focus narrowly on isolated mechanisms or pathologies, lacking systematic analysis of these bidirectional interactions or comprehensive therapeutic evaluations. Here, we synthesize current knowledge on GS anatomy, functional regulators, and assessment techniques. We critically examine bidirectional GS-disease relationships, emphasizing disrupted fluid dynamics in neurodegeneration, cerebrovascular pathology, and neuroinflammation. Furthermore, we evaluate emerging GS-targeted therapies, discussing their translational potential and limitations. By integrating basic and clinical perspectives, this study advances a unified framework for understanding neuropathological mechanisms and developing novel interventions targeting glymphatic pathways.